Alpine Immune Sciences (ALPN)
(Delayed Data from NSDQ)
$64.60 USD
0.00 (0.00%)
Updated May 6, 2024 04:00 PM ET
After-Market: $64.58 -0.02 (-0.03%) 6:36 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Alpine Immune Sciences, Inc. [ALPN]
Reports for Purchase
Showing records 121 - 140 ( 153 total )
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
EULAR 2020 Takeaways: ALPN-101 HV Update and New B Cell Preclinical Programs
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Q1 Financials; First Patient Dosed in BALANCE Acute GvHD Study
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
CORRECTED AACR 2020 Titles for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Q4 Financials; BALANCE and NEON-1 Studies Now Open for Enrollment
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
ALPN-101 Healthy Volunteer Safety Looks Clean; BALANCE Study Details Announced
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Q3 Financials; ALPN-101 Data Presentation at ASH Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Biotechnology - SITC 2019 Abstract Title Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Q2 Financials; IND for ALPN-202 on Track for 2H:19
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
2019 PacGrow Healthcare Conference: Day 1 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Adaptimmune taps Alpine Immune for 2nd Gen. TCR Therapies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
Q1 Financials; Recent Financing Supports Versatile Platform
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Alpine Immune Sciences, Inc.
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.